After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five 04/08/2022 Elaine Ruth Fletcher The United States is considering shifting to intradermal injections of Monkeypox vaccine that could potentially stretch one dose of the approved MVA-BN vaccine, available only in limited quantities, into five doses, said US Food and Drug Administration Commissioner Robert Califf on Thursday. He was speaking at a press briefing minutes after Xavier Becerra, US Secretary […] Continue reading -> Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 29/07/2022 Kerry Cullinan MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading -> Thanks to COVID-19, Alarm Grows Over Drug Resistant Infections 26/07/2022 Catherine Davison, via The New Humanitarian (DELHI, India via The New Humanitarian) – As medical professionals across the globe grappled with COVID-19 infections, microbiologist Dr. Bhavani Eshwaragari was confronting a quieter – though no less dangerous – pandemic. Reviewing patient samples in her laboratory in Continental Hospital in the southern India city of Hyderabad, she began to notice an alarming trend […] Continue reading -> Tackling Barriers to Africa’s Scientific Innovation – From Lack of Skills to Afro-pessimism 20/07/2022 Kerry Cullinan COVID-19 exposed Africa’s vulnerabilities and its urgent need for local innovation and drug development. Leading African scientist KELLY CHIBALE discusses some of the key challenges. Improving scientific skills in Africa and stemming the continent’s brain drain weigh heavily on Professor Kelly Chibale’s mind, particularly as COVID-19 pandemic has damaged fragile health systems and reversed hard-fought […] Continue reading -> Could a Substance Derived from Broccoli Play a Role in Reducing AMR? 15/07/2022 Maayan Hoffman Researchers worldwide are searching for ways to reduce dependence on antibiotics to preserve these life-saving medicines in the face of the rise in antibiotic-resistant bacteria. Drug resistance is currently implicated in 700,000 deaths each year, and the World Health Organization (WHO) raised the red flag last month over the lack of new antibacterial treatments being […] Continue reading -> Race to Develop Omicron-proof Boosters Before Northern Winter 14/07/2022 Kerry Cullinan Vaccine manufacturers are in a race to develop or tweak COVID-19 vaccines to address the Omicron variants that are sweeping through the globe – and get them ready for use as boosters when the weather cools in the northern hemisphere. More infectious Omicron strains BA.4 and BA.5 have become dominant in many parts of the […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 29/07/2022 Kerry Cullinan MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading -> Thanks to COVID-19, Alarm Grows Over Drug Resistant Infections 26/07/2022 Catherine Davison, via The New Humanitarian (DELHI, India via The New Humanitarian) – As medical professionals across the globe grappled with COVID-19 infections, microbiologist Dr. Bhavani Eshwaragari was confronting a quieter – though no less dangerous – pandemic. Reviewing patient samples in her laboratory in Continental Hospital in the southern India city of Hyderabad, she began to notice an alarming trend […] Continue reading -> Tackling Barriers to Africa’s Scientific Innovation – From Lack of Skills to Afro-pessimism 20/07/2022 Kerry Cullinan COVID-19 exposed Africa’s vulnerabilities and its urgent need for local innovation and drug development. Leading African scientist KELLY CHIBALE discusses some of the key challenges. Improving scientific skills in Africa and stemming the continent’s brain drain weigh heavily on Professor Kelly Chibale’s mind, particularly as COVID-19 pandemic has damaged fragile health systems and reversed hard-fought […] Continue reading -> Could a Substance Derived from Broccoli Play a Role in Reducing AMR? 15/07/2022 Maayan Hoffman Researchers worldwide are searching for ways to reduce dependence on antibiotics to preserve these life-saving medicines in the face of the rise in antibiotic-resistant bacteria. Drug resistance is currently implicated in 700,000 deaths each year, and the World Health Organization (WHO) raised the red flag last month over the lack of new antibacterial treatments being […] Continue reading -> Race to Develop Omicron-proof Boosters Before Northern Winter 14/07/2022 Kerry Cullinan Vaccine manufacturers are in a race to develop or tweak COVID-19 vaccines to address the Omicron variants that are sweeping through the globe – and get them ready for use as boosters when the weather cools in the northern hemisphere. More infectious Omicron strains BA.4 and BA.5 have become dominant in many parts of the […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Thanks to COVID-19, Alarm Grows Over Drug Resistant Infections 26/07/2022 Catherine Davison, via The New Humanitarian (DELHI, India via The New Humanitarian) – As medical professionals across the globe grappled with COVID-19 infections, microbiologist Dr. Bhavani Eshwaragari was confronting a quieter – though no less dangerous – pandemic. Reviewing patient samples in her laboratory in Continental Hospital in the southern India city of Hyderabad, she began to notice an alarming trend […] Continue reading -> Tackling Barriers to Africa’s Scientific Innovation – From Lack of Skills to Afro-pessimism 20/07/2022 Kerry Cullinan COVID-19 exposed Africa’s vulnerabilities and its urgent need for local innovation and drug development. Leading African scientist KELLY CHIBALE discusses some of the key challenges. Improving scientific skills in Africa and stemming the continent’s brain drain weigh heavily on Professor Kelly Chibale’s mind, particularly as COVID-19 pandemic has damaged fragile health systems and reversed hard-fought […] Continue reading -> Could a Substance Derived from Broccoli Play a Role in Reducing AMR? 15/07/2022 Maayan Hoffman Researchers worldwide are searching for ways to reduce dependence on antibiotics to preserve these life-saving medicines in the face of the rise in antibiotic-resistant bacteria. Drug resistance is currently implicated in 700,000 deaths each year, and the World Health Organization (WHO) raised the red flag last month over the lack of new antibacterial treatments being […] Continue reading -> Race to Develop Omicron-proof Boosters Before Northern Winter 14/07/2022 Kerry Cullinan Vaccine manufacturers are in a race to develop or tweak COVID-19 vaccines to address the Omicron variants that are sweeping through the globe – and get them ready for use as boosters when the weather cools in the northern hemisphere. More infectious Omicron strains BA.4 and BA.5 have become dominant in many parts of the […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Tackling Barriers to Africa’s Scientific Innovation – From Lack of Skills to Afro-pessimism 20/07/2022 Kerry Cullinan COVID-19 exposed Africa’s vulnerabilities and its urgent need for local innovation and drug development. Leading African scientist KELLY CHIBALE discusses some of the key challenges. Improving scientific skills in Africa and stemming the continent’s brain drain weigh heavily on Professor Kelly Chibale’s mind, particularly as COVID-19 pandemic has damaged fragile health systems and reversed hard-fought […] Continue reading -> Could a Substance Derived from Broccoli Play a Role in Reducing AMR? 15/07/2022 Maayan Hoffman Researchers worldwide are searching for ways to reduce dependence on antibiotics to preserve these life-saving medicines in the face of the rise in antibiotic-resistant bacteria. Drug resistance is currently implicated in 700,000 deaths each year, and the World Health Organization (WHO) raised the red flag last month over the lack of new antibacterial treatments being […] Continue reading -> Race to Develop Omicron-proof Boosters Before Northern Winter 14/07/2022 Kerry Cullinan Vaccine manufacturers are in a race to develop or tweak COVID-19 vaccines to address the Omicron variants that are sweeping through the globe – and get them ready for use as boosters when the weather cools in the northern hemisphere. More infectious Omicron strains BA.4 and BA.5 have become dominant in many parts of the […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Could a Substance Derived from Broccoli Play a Role in Reducing AMR? 15/07/2022 Maayan Hoffman Researchers worldwide are searching for ways to reduce dependence on antibiotics to preserve these life-saving medicines in the face of the rise in antibiotic-resistant bacteria. Drug resistance is currently implicated in 700,000 deaths each year, and the World Health Organization (WHO) raised the red flag last month over the lack of new antibacterial treatments being […] Continue reading -> Race to Develop Omicron-proof Boosters Before Northern Winter 14/07/2022 Kerry Cullinan Vaccine manufacturers are in a race to develop or tweak COVID-19 vaccines to address the Omicron variants that are sweeping through the globe – and get them ready for use as boosters when the weather cools in the northern hemisphere. More infectious Omicron strains BA.4 and BA.5 have become dominant in many parts of the […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Race to Develop Omicron-proof Boosters Before Northern Winter 14/07/2022 Kerry Cullinan Vaccine manufacturers are in a race to develop or tweak COVID-19 vaccines to address the Omicron variants that are sweeping through the globe – and get them ready for use as boosters when the weather cools in the northern hemisphere. More infectious Omicron strains BA.4 and BA.5 have become dominant in many parts of the […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Posts navigation Older posts